Blue Owl Technology Finance Corp. (OTF)

On our desk, we are looking closely at OTF trading at roughly a 39% discount to its reported NAV of $16.49. While the 13.9% base dividend yield looks visually enticing, we note that second-quarter adjusted NII per share came in at $0.30, which leaves base dividend coverage tight. Management is targeting coverage improvements by mid-next year, but right now the market is demanding a steep risk premium due to the combination of software exposure and broader private credit sentiment.

From a credit risk management standpoint, OTF's underlying performance metrics look surprisingly resilient. Non-accruals remain extremely low at approximately 10 basis points, and 91.5% of portfolio assets are rated at or above expectations. However, the legal overhang involving multiple lawsuits across the adviser, parent company, and sister BDCs creates an extra layer of headline risk that keeps institutional capital hesitant despite the double-digit return potential.

Watching the 50-day MA and recent Q2 2026 earnings execution, total investment income rose 5.8% year-over-year to $338.0 million, driven by active new commitments of roughly $850 million and $550 million in funded investments. Yet, operating expenses expanded faster than top-line income, pushing net debt-to-equity up to 0.93x. The Q2 GAAP diluted EPS decline to $0.33 confirms that margin compression remains a tangible hurdle for near-term earnings growth.

As a bio-analyst tracking tech and software debt covenants, I find OTF's 70% software exposure both a core strength and a key vulnerability. The upper middle-market tech companies they target have sticky, mission-critical products which help mitigate immediate AI disruption risks. Even so, analysts must model how gradual secular shifts in software spending could eventually impact portfolio marks and valuation marks over multi-year horizons.

In our quantitative scenario analyses, buying OTF at a valuation of around $10.10 against a $16.48 NAV implies an aggressive downside dislocation. Our bull case outlines up to 47% upside if valuation multiples revert toward book value, whereas the bear case only implies a modest 10% further downside given the substantial discount already priced into the units. A staggered accumulation strategy seems most prudent given the volatile macro backdrop.